Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7 Neoplasms by Histologic Type 3 Neoplasms 3 Gastro-enteropancreatic neuroendocrine tumor 3 Neuroendocrine Tumors 2 Lymphoproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lymphatic Diseases 2 Immune System Diseases 2 Digestive System Neoplasms 2 AIDS-Related Complex 2 Urogenital Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Pancreatic Diseases 1 Neuroectodermal Tumors 1 Neoplasms, Nerve Tissue 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 Standard of Care 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Midazolam 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Lutetium × Clear all

NCT06320067 2025-09-26

STAMPEDE2

University College, London

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡